• Guideline Summary
  • NGC:010262
  • 2011 Feb (revised 2013 Feb)

Optimal excision margins for primary cutaneous melanoma.

  • Guideline Summary
  • NGC:010860
  • 2015 Nov 25

Pembrolizumab for advanced melanoma not previously treated with ipilimumab.

  • Guideline Summary
  • NGC:010571
  • 2014 Oct

Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma.

  • Guideline Summary
  • NGC:009201
  • 2012 Jul 9

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.

  • Guideline Summary
  • NGC:009518
  • 2012 Dec

Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma.

  • Guideline Summary
  • NGC:009517
  • 2012 Dec

Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma.

  • Guideline Summary
  • NGC:010783
  • 2015 Jul 29

Melanoma: assessment and management.

  • Guideline Summary
  • NGC:010264
  • 2012 Mar (revised 2013 Feb)

Preoperative and pretreatment investigations for malignant melanoma.

  • Guideline Summary
  • NGC:010817
  • 2015 Oct 7

Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab.

  • Guideline Summary
  • NGC:010344
  • 2011 Feb (revised 2014 Feb)

Sentinel node biopsy in primary cutaneous melanoma.

  • Guideline Summary
  • NGC:010248
  • 2012 Mar (revised 2013 Feb)

Biopsy of a suspicious pigmented lesion.

  • Guideline Summary
  • NGC:009038
  • 2001 Mar (revised 2011 Nov)

Guidelines of care for the management of primary cutaneous melanoma.

  • Guideline Summary
  • NGC:010882
  • 2015 Aug

Systemic therapy for unresectable stage III or metastatic cutaneous melanoma.

  • Guideline Summary
  • NGC:009386
  • 2012 Mar

Adjuvant radiation for malignant melanoma.

  • Guideline Summary
  • NGC:010266
  • 2011 Feb (revised 2013 Feb)

Referral and follow-up surveillance of cutaneous melanoma.

  • Guideline Summary
  • NGC:010377
  • 2014 Feb

Adjuvant interferon for malignant melanoma.

  • Expert Commentary

Importance of Quality Metrics for Providing High Quality Melanoma Care

  • Guideline Summary
  • NGC:010260
  • 2010 May (revised 2013 Feb)

Management of resectable stage IV primary cutaneous melanoma without nodal disease.

  • Guideline Summary
  • NGC:010259
  • 2010 May (revised 2013 Feb)

Management of in-transit disease of the limbs.

  • Guideline Summary
  • NGC:010901
  • 2016 Feb 10

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over.